Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
boston blog main
7
×
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
7
×
deals
7
×
detroit blog main
7
×
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
fda
cancer immunotherapy
bristol-myers squibb
eli lilly
investing
takeda pharmaceutical
abbvie
biogen
drug prices
What
roundup
bio
drug
ahead
asco
cancer
cash
companies
days
drugs
fda
growing
nash
news
acquisitions
alliance
ambien
american
announced
annual
appetite
approval
approved
attendees
attention
biogen’s
biopharmaceutical
biotech
black
branded
bread
bristol
butter
buy
buyout
calls
camp’s
ceo
changing
chicago
Language
unset
Current search:
biotech
×
deals
×
" clinical trials "
×
" boston blog main "
×
" detroit blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More